Targeting prolyl-isomerase Pin1 prevents mitochondrial oxidative stress and vascular dysfunction: insights in

Francesco Paneni1, Sarah Costantino2, Lorenzo Castello3

  • 1Cardiology and Cardiovascular Research, Institute of Physiology and University Hospital, Zürich, Switzerland Cardiology Unit, Department of Medicine, Karolinska University Hospital, Solna, 171 76 Stockholm, Sweden IRCCS Neuromed, Pozzilli, Italy.

Abstract

Insights

Prolyl-isomerase Pin1 drives diabetic vascular disease by promoting mitochondrial oxidative stress and inflammation. Inhibiting Pin1 may offer novel therapeutic strategies for diabetes-related cardiovascular complications.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Diabetes mellitus is a significant risk factor for cardiovascular disease, with underlying molecular mechanisms requiring elucidation.
  • Prolyl-isomerase Pin1 is a key regulator of protein function and cellular homeostasis.
  • The specific role of Pin1 in the pathogenesis of diabetes-induced vascular complications is not well understood.

Purpose of the Study:

  • To investigate the role of Prolyl-isomerase Pin1 in the development of vascular disease associated with diabetes.
  • To elucidate the molecular mechanisms by which Pin1 contributes to diabetes-induced endothelial dysfunction and inflammation.

Main Methods:

  • Experiments were conducted using human aortic endothelial cells (HAECs) exposed to high glucose conditions.
  • Studies involved gene silencing of Pin1, assessment of mitochondrial translocation of p66(Shc), nitric oxide (NO) availability, and nuclear translocation of NF-κB p65.
  • Diabetic Pin1 knockout mice were utilized to evaluate in vivo effects on mitochondrial oxidative stress, endothelial function, and vascular inflammation.
  • Peripheral blood monocytes from diabetic patients and healthy controls were analyzed for Pin1 expression and activity.

Main Results:

  • High glucose induced Pin1 upregulation in HAECs, leading to p66(Shc) mitochondrial translocation, oxidative stress, and endothelial nitric oxide synthase (eNOS) dysregulation.
  • Pin1 mediated hyperglycaemia-induced NF-κB p65 nuclear translocation, increasing expression of inflammatory markers (VCAM-1, ICAM-1, MCP-1).
  • Pin1 gene silencing in HAECs reversed these detrimental effects, while diabetic Pin1(-/-) mice showed protection against vascular damage.
  • Elevated Pin1 expression and activity were observed in monocytes from diabetic patients, correlating with impaired vascular function and increased markers of oxidative stress and inflammation.

Conclusions:

  • Pin1 plays a critical role in driving diabetic vascular disease through mechanisms involving mitochondrial oxidative stress, eNOS dysregulation, and NF-κB-mediated inflammation.
  • These findings offer novel molecular insights into the pathogenesis of diabetic vascular complications.
  • Targeting Pin1 presents a potential therapeutic strategy for managing diabetes-related cardiovascular diseases.

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
11.9K
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
32